Your Thymus Keeps Protecting You Into Old Age — and AI Can Now Measure How Well

For decades, the thymus — the organ responsible for producing and diversifying T cells — was considered functionally obsolete in adults. The prevailing view held that once a diverse T cell repertoire is established in childhood, peripheral maintenance is sufficient. This study, published in Nature, directly challenges that assumption with large-scale epidemiological evidence.

The research team built a deep learning pipeline trained on 5,674 CT scans to automatically localize the thymus and quantify its composition as a continuous proxy for thymic functionality, termed 'thymic health.' The system was then validated on 27,612 individuals from two independent prospective cohorts: the National Lung Screening Trial (NLST, n=25,031) and the Framingham Heart Study (FHS, n=2,581). Participants were stratified into low (bottom 25%), average (middle 50%), and high (top 25%) thymic health categories.

In the NLST, higher thymic health was consistently associated with lower all-cause mortality, reduced lung cancer incidence, and lower cardiovascular mortality over 12 years of follow-up, after adjustment for age, sex, smoking status, and comorbidities. These findings were independently replicated in the FHS, where higher thymic health was significantly associated with reduced cardiovascular mortality. The convergence of results across two distinct cohorts with different designs substantially strengthens the causal argument.

Thymic health also correlated with systemic inflammation and metabolic dysregulation, suggesting mechanistic pathways through which thymic decline may accelerate age-related disease. Critically, several determinants of thymic health were modifiable: smoking, obesity, and physical inactivity were each associated with lower thymic health, while female sex and younger age predicted higher values — consistent with known biology of thymic involution.

These findings reframe thymic health as a measurable, potentially modifiable biomarker of immunological ageing. They open clinical avenues for thymus-targeting interventions — from lifestyle modification and metabolic optimization to experimental regenerative strategies — as tools to promote healthy ageing. The ability to assess thymic health non-invasively from routine CT scans, which are already widely used in lung cancer screening, makes population-level application feasible.